Filter Results:
(1,710)
Show Results For
- All HBS Web
(1,710)
- News (262)
- Research (1,291)
- Events (5)
- Multimedia (3)
- Faculty Publications (604)
Show Results For
- All HBS Web
(1,710)
- News (262)
- Research (1,291)
- Events (5)
- Multimedia (3)
- Faculty Publications (604)
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
- Web
Students on the Job Market - Doctoral
Placement Students on the Job Market Please note this page will be updated throughout the fall. Accounting & Management Terrence Tianshuo Shi Abstract: Forthcoming Faculty Advisor(s): | Email Elliot Tobin Abstract: The Effects of... View Details
- March 2005
- Teaching Note
Antitrust Regulations in a Global Setting: The EU Investigation of the GE/Honeywell Merger (TN)
By: Mihir A. Desai and Belen Villalonga
Teaching Note to (9-204-081). View Details
- 2023
- Government Testimony
Congressional Statement for the Record, Hearing on Factors Influencing the High Cost of Insurance for Consumers
By: Ishita Sen
Sen, Ishita. "Congressional Statement for the Record, Hearing on Factors Influencing the High Cost of Insurance for Consumers." Government Testimony, U.S. House of Representatives, Committee on Financial Services, Subcommittee on Housing and Insurance, November 2023.
- Blog Post
Health Care Transparency: The Fox Is Guarding the Chicken Coop in Washington Again
Now that more people can shop directly for their own health insurance under the Affordable Care Act, they have been transformed from potential patients to consumers, and like any other consumers of goods or services, they want to know if what they're buying is any... View Details
Herzlinger, Regina E. "Health Care Transparency: The Fox Is Guarding the Chicken Coop in Washington Again." Huffington Post, The Blog (March 24, 2014). http://www.huffingtonpost.com/regina-e-herzlinger/health-care-transparency_b_5022531.html.
- August 2019
- Case
The Allstate Corporation, 2019
By: John R. Wells and Benjamin Weinstock
In July 2019, Allstate, the United States’ number-three property and casualty (P/C) insurer, released its second-quarter earnings, which reported first-half revenues of $22.1 billion, up 11.4% year-over-year. Shareholders cheered the top-line growth, but P/C premiums... View Details
Keywords: Insurance Companies; Strategic Analysis; Strategic Change; Insurance; Strategy; Strategic Planning; Organizational Change and Adaptation; Competitive Strategy; Insurance Industry; North America
Wells, John R., and Benjamin Weinstock. "The Allstate Corporation, 2019." Harvard Business School Case 720-366, August 2019.
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Pharmaceutical Industry; Health Industry; Retail Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- 2023
- Working Paper
The Market for Sharing Interest Rate Risk: Quantities and Asset Prices
By: Umang Khetan, Jane Li, Ioana Neamtu and Ishita Sen
We study the extent of interest rate risk sharing across the financial system using granular positions and transactions data in interest rate swaps. We show that pension and insurance (PF&I) sector emerges as a natural counterparty to banks and corporations: overall,... View Details
Keywords: Interest Rates; Investment Funds; Banks and Banking; Insurance; Investment Banking; Risk and Uncertainty
Khetan, Umang, Jane Li, Ioana Neamtu, and Ishita Sen. "The Market for Sharing Interest Rate Risk: Quantities and Asset Prices." Harvard Business School Working Paper, No. 24-052, February 2024.
- Web
Research & Teaching - Creating Emerging Markets
indicate about the respective market environments? How did business leaders in India, Chile and the Gulf respond to the liberalization of regulation in their respective countries? What challenges did... View Details
- September 2018 (Revised August 2019)
- Case
The Progressive Corporation, 2018
By: John R. Wells and Benjamin Weinstock
In early 2019, The Progressive Corporation (Progressive), the USA’s third-largest auto insurance writer, reported earned premiums were up 20% in 2018 compared to the previous year, and net income was up 64%. Direct sales of personal auto policies rose 21%, while agent... View Details
Keywords: Insurance Companies; Strategic Analysis; Strategic Decisions; Customer Acquisition; Customer Experience; Customer Lifetime Value; Policy Implementation; Competitors; Auto Insurance; Vehicle; Progressive; Allstate; State Farm; GEICO; Implementation; Insurance; Customer Value and Value Chain; Growth Management; Competitive Strategy; Insurance Industry
Wells, John R., and Benjamin Weinstock. "The Progressive Corporation, 2019." Harvard Business School Case 719-413, September 2018. (Revised August 2019.)
- Article
Holdout in the Assembly of Complements: A Problem for Market Design
By: Scott Duke Kominers and E. Glen Weyl
Holdout problems prevent private (voluntary and self-financing) assembly of complementary goods—such as land or dispersed spectrum—from many self-interested sellers. While mechanisms that fully respect sellers' property rights cannot alleviate these holdout problems,... View Details
Kominers, Scott Duke, and E. Glen Weyl. "Holdout in the Assembly of Complements: A Problem for Market Design." American Economic Review: Papers and Proceedings 102, no. 3 (May 2012): 360–365.
- 10 Dec 2008
- Working Paper Summaries
Market Reaction to the Adoption of IFRS in Europe
- 06 Jun 2013
- Working Paper Summaries
Do Strict Capital Requirements Raise the Cost of Capital? Banking Regulation and the Low Risk Anomaly
- 09 Apr 2024
- News
To Serve and Protect the Markets
Every day, in her role as the director of the Atlanta Regional Office of the Securities and Exchange Commission (SEC), Nekia Hackworth Jones (MBA 2004) stands in the breach between the $100 trillion in securities traded on U.S. equity View Details
Keywords: Margie Kelley
- Fast Answer
Stock market capitalization: exchanges, industries, countries
Where can I find stock market capitalization for an exchange, index or country? Global Financial Data World Development Indicators Select... View Details
- 05 Nov 2009
- Research & Ideas
A Market for Human Cadavers in All but Name?
Views of Market Society." Annual Review of Sociology 22:285-311. Goodwin, Michele. 2006. Black Markets: The Supply and Demand of Body Parts. New York, NY: Cambridge University Press. Harrington, David E., and Edward A. Sayre. 2006.... View Details
- August 2012 (Revised March 2014)
- Technical Note
4M: Four-Markets Analysis for Emerging Economies
By: Eric Werker
This technical note describes a methodology for evaluating the political economy of business-government relations in an emerging or frontier economy. The note argues that there are not one but four markets in an emerging economy: the market of "rentiers" such as mining... View Details
Werker, Eric. "4M: Four-Markets Analysis for Emerging Economies." Harvard Business School Technical Note 713-026, August 2012. (Revised March 2014.)
- 01 Aug 2008
- Research & Ideas
Does Market Capitalism Have a Future?
We showed it to important business leaders—some HBS alumni, some not—from around the world and asked them for their views on potential problem areas and what role HBS might play in addressing them. The fact is that in many parts of the world, firms are not privately... View Details
Keywords: by Garry Emmons